Mankhwala okonzekera 'Osasamala'. Malangizo ogwiritsidwa ntchito

Malangizo a "Mildronate" omwe amagwiritsidwa ntchito ngati njira yomwe ingathandize kusintha kagayidwe ka kagayidwe kake, kuchepetsa mphamvu, kuchepetsa mawonetseredwe a m'maganizo ndi thupi. Mankhwalawa ndi ntchito yake akhoza kuteteza chitetezo m'maselo ndipo ali ndi matenda a mtima. Kuonjezera apo, mankhwalawa amathandiza kuthetsa mavuto omwe amagwira ntchito m'thupi mwa anthu omwe amadwala mowa ndi matenda obisala. Pogwiritsira ntchito Mildronate, kubwezeretsedwa kwa magazi m'madera osokonezeka ndi kotheka, omwe ali mu ubongo ndi retina.

Kukonzekera "Zopanda Pake" kumaperekedwa ngati ma kapsules otsogolera pakamwa komanso njira yothetsera jekeseni. Monga mankhwala ndi mankhwala ena aliwonse odzala ndi makatoni ndipo amalowa mumagulu a mankhwala.

Ma Capsules ali ndi gelatinous yolimba ya mtundu woyera, mkati mwawo ndi crystalline powdery mankhwala.

Yankho la jekeseni ndi madzi omveka bwino omwe alibe mtundu ndi fungo.

Mukhoza kugula mankhwala kuchipatala chilichonse, koma mankhwala okhaokha.

Dokotala amaperekanso mankhwala kuchipatala ngati zifukwa izi zikuwonetsedwa mwa wodwalayo:

- kulephera mtima mtima ,

- kuthamanga kwa myocardial infarction,

- angina pectoris,

- matenda osapitirira komanso ovuta kwambiri m'magazi,

- Matenda obisala.

Pazifukwa izi, "Mildronate" ndi mankhwala omwe ndi mbali ya mankhwala ovuta.

Ndiponso, kukonzekera kumasonyezedwa kuti ntchito:

• Ndi kuchepa kwachangu,

• Pofuna kuchepetsa nthawi ya kukonzanso pambuyo pa opaleshoni,

• Pogwiritsa ntchito thupi,

• Ndi thrombosis ya mitsempha ya pakati pa retina,

• Ndi kuchepa kwa magazi mu retina wa diso,

• Ali ndi matenda opatsirana kwambiri a shuga,

• Monga immunomodulator wa matenda aakulu a bronchitis ndi bronchial mphumu.

Mofanana ndi mankhwala ena onse, mankhwalawa "Mildronate" (malangizo ogwiritsidwa ntchito ali ndi mfundo pa izi) alibe zizindikiro zokhazokha, koma zotsutsana.

Ntchito yogwiritsira ntchito mankhwala osagwirizana ndi zigawo zilizonse za mankhwala. Komanso, Mildronate sayenera kuyendetsedwa ndi kupanikizika kwa mankhwala osokoneza bongo komanso kupezeka kwa zotupa zopanda pake.

Sikoyenera kuti mugwiritse ntchito mankhwalawa kwa amayi omwe ali ndi pakati komanso omwe akulera.

Palibe zotsatirapo za mankhwalawa, koma nthawi zambiri zimakhala zosautsa, kuwonjezeka kwa mtima komanso kuthamanga kwa magazi.

Kuwonjezera pa chidziwitso chodziwikiratu cha kukonzekera kochepa, malangizo a ntchito amapereka chidziwitso chodabwitsa pa njira zogwiritsira ntchito ndi ma dosing.

Matenda a mtima

Pogwiritsa ntchito angina pectoris (stable), pogwiritsira ntchito monga mankhwala ovuta, yambani kusankha 250x3 (masiku anai), ndiye 250x3 kawiri pa sabata (kwa miyezi limodzi ndi theka).

M'madera a myocardial infarction ndi angina (osasunthika), majekisoni opatsirana amauzidwa: 0.5-1x1, ndiye masentimita 250x2 (masiku anai), ndiye 250x3 kawiri mlungu uliwonse.

Chifukwa cha kuphwanya kwa ubongo (mu gawo lovuta), Mildronate imaperekedwa ngati majekeseni a intravenous a 0.5x1 (masiku khumi), ndiye m'mapiritsi imodzi pa tsiku.

Ngati wodwalayo ali ndi matenda oopsa kwambiri a retina, ndiye kuti Mildronate amapatsidwa parabulbar pa 50 milligrams pa tsiku (kwa masiku khumi).

Zinthu zakuthupi ndi zamaganizo

Mu mawonekedwe a makapisozi a 0.25x3 kapena mwa mawonekedwe a injection intravenous 500x1 (masabata awiri). Ngati kuli kotheka, maphunzirowo akhoza kubwerezedwa.

Kwa othamanga, Mildronate imapatsidwa nthawi yophunzitsidwa kwambiri mu makapulisi a 1x2 (masabata awiri).

Muuchidakwa chosatha, mankhwala amaperekedwa monga ma kapsules a 0.5 × 4 kapena mawonekedwe a injection intravenous ya 0.5 × 2 (masiku khumi).

Mu mankhwala ovuta a mphumu yowonongeka, Mildronate imaperekedwa pa 0.25 magalamu tsiku lililonse kwa masiku makumi awiri ndi limodzi.

Pangani kukonzekera "Zosakaniza" (malangizo othandizira ntchitoyi) ayenera kukhala kutentha kutentha m'chipinda chouma. Komanso, chisamaliro chiyenera kuchitidwa kuti zitsimikizidwe kuti kusungirako mankhwala sikupezeka kwa ana.